KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Net Income (2018 - 2025)

Historic Net Income for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $91.3 million.

  • BioNTech SE's Net Income fell 5803.26% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$605.1 million, marking a year-over-year decrease of 98240.58%. This contributed to the annual value of -$737.4 million for FY2024, which is 14753.38% down from last year.
  • As of Q3 2025, BioNTech SE's Net Income stood at $91.3 million, which was down 5803.26% from -$474.1 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Net Income peaked at $7.2 billion during Q4 2021, and registered a low of -$865.6 million during Q2 2024.
  • Moreover, its 5-year median value for Net Income was $539.0 million (2023), whereas its average is $1.7 billion.
  • In the last 5 years, BioNTech SE's Net Income skyrocketed by 163746041825.11% in 2021 and then crashed by 31749.74% in 2024.
  • BioNTech SE's Net Income (Quarter) stood at $7.2 billion in 2021, then tumbled by 67.54% to $2.3 billion in 2022, then tumbled by 59.81% to $934.5 million in 2023, then crashed by 70.32% to $277.3 million in 2024, then plummeted by 67.07% to $91.3 million in 2025.
  • Its Net Income was $91.3 million in Q3 2025, compared to -$474.1 million in Q2 2025 and -$499.6 million in Q1 2025.